FPGS

Folylpolyglutamate Synthase

Gene Information Card

Symbol FPGS
Full Name Folylpolyglutamate Synthase
Gene Type Protein coding
Chromosomal Location 9q34.11
NCBI Gene ID 2356 ncbi.nlm.nih.gov/gene/2356
Ensembl ID ENSG00000136872
UniProt ID Q05932
OMIM ID 136510
HGNC ID 3824
Aliases FPGS, FLJ10631, MGC102966

Description

The FPGS gene encodes folylpolyglutamate synthase, a mitochondrial and cytoplasmic enzyme that catalyzes the addition of glutamate residues to folate and antifolate polyglutamates. This polyglutamation is essential for intracellular folate retention and for the synthesis of cofactors required for nucleotide biosynthesis, amino acid metabolism, and methylation reactions. FPGS activity is critical for cellular proliferation and is a determinant of response to antifolate chemotherapeutics such as methotrexate.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Methotrexate Resistance Reduced FPGS expression or activity leads to decreased polyglutamation of methotrexate, impairing its intracellular retention and efficacy. ClinVar, COSMIC
Folate Deficiency Loss-of-function mutations in FPGS can cause impaired folate polyglutamation, leading to cellular folate deficiency and megaloblastic anemia. OMIM
Colorectal Cancer Altered FPGS expression is associated with prognosis and response to 5-fluorouracil-based chemotherapy. COSMIC

Expression Profile

Tissue Expression
Tissue nTPM level
Liver 12.5 Medium
Kidney 10.2 Medium
Small Intestine 8.9 Medium
Bone Marrow 6.3 Low
Brain 2.1 Low
Cell Line Expression
Cell Line nTPM Notes
HeLa 15.4 Cervical cancer cell line
MCF7 11.2 Breast cancer cell line
HepG2 13.8 Hepatocellular carcinoma cell line
K562 7.5 Leukemia cell line
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.452C>T (p.Pro151Leu) Missense Rare Reduced enzyme activity, associated with folate deficiency
c.1016G>A (p.Arg339Gln) Missense Rare Impaired methotrexate polyglutamation, linked to drug resistance
c.1A>G (p.Met1Val) Start loss Very rare Loss of function, severe folate deficiency
Mutation functional classification

Loss of Function (LOF)

Missense and start-loss mutations reduce or abolish polyglutamate synthase activity, leading to folate deficiency and methotrexate resistance.

Gain of Function (GOF)

No gain-of-function mutations are currently documented in ClinVar or COSMIC.

Dominant Negative (DN)

No dominant-negative mutations have been reported for FPGS.

Pathways

Folate metabolism (Reactome: R-HSA-196757)
Methotrexate action (KEGG: hsa00230)
One-carbon metabolism (KEGG: hsa00670)

Protein Summary

Folylpolyglutamate synthase (FPGS) is a 587-amino acid protein that catalyzes the ATP-dependent addition of glutamate residues to folate and antifolate substrates. The enzyme exists in two isoforms: a mitochondrial form (with a leader sequence) and a cytoplasmic form. FPGS is essential for maintaining intracellular folate pools and for the synthesis of polyglutamated cofactors required for purine and thymidylate biosynthesis. Its activity is a key determinant of cellular sensitivity to antifolate drugs like methotrexate.

Related Products

Product name Cat.No. Species Gene ID
FPGS Knockout HEK293 Cell Line EDJ-KQ4622 Human 2356 Details Get a Quote
FPGS Knockout A-549 Cell Line EDJ-KQ27293 Human 2356 Details Get a Quote
FPGS Knockout HCT 116 Cell Line EDJ-KQ27294 Human 2356 Details Get a Quote
FPGS Knockout HeLa Cell Line EDJ-KQ27295 Human 2356 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: